Theravance Biopharma, Inc. (TBPH)
16.34
-0.21
(-1.27%)
USD |
NASDAQ |
May 21, 16:00
16.32
-0.02
(-0.09%)
After-Hours: 19:59
Theravance Biopharma Accounts Payable (Quarterly) : 1.10M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Viatris, Inc. | 1.200B |
| Relmada Therapeutics, Inc. | 5.731M |
| Indivior Pharmaceuticals, Inc. | 35.00M |
| Corcept Therapeutics, Inc. | 33.31M |
| Assertio Holdings, Inc. | 5.913M |